Burkhardt Glen

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Burkhardt Glen's trades of PhaseBio Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
263.16
Quantity 91,500 +50.0%
Value US$2,256,258
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-24 2022-05-23
PlS Planned sale
60,749 -19.8%
462.01
US$2,876,297 		60,749 -19.8% 462.01 US$2,876,297
2021-11-23 2021-11-19
PlS Planned sale
92,380 +20.7%
207.32
US$4,234,913 		92,380 +20.7% 207.32 US$4,234,913
2021-05-24 2021-05-20
S Sale
91,500 +50.0%
263.16
US$2,256,258 		91,500 +50.0% 263.16 US$2,256,258
2020-11-23 2020-11-23
S Sale
3,497 -100.0%
3.45
US$12,065 		3,497 -100.0% 3.45 US$12,065